Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

显示完整简历 隐藏完整简历

最新新闻和观点

empty-chairs
技术、媒体与通信 (TMC)

Intellectual property licences and insolvency

2 七月 2020
IN-DEPTH ANALYSIS

作者 Adrian Toutoungi 以及 Charlie Adams

点击此处了解更多
Mobile Communications
专利与创新

IPCom v Lenovo – Court of Appeal of Paris

23 六月 2020
IN-DEPTH ANALYSIS

作者 Adrian Toutoungi 以及 Eelco Bergsma

点击此处了解更多
scientist-with-vials
酒店与休闲

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22 六月 2020
IN-DEPTH ANALYSIS

作者 Adrian Toutoungi 以及 Josef Fuss

点击此处了解更多
black-robotic-arm
Synapse

COVID-19 postponement of MDR implementation date – how does this fit with Brexit?

26 五月 2020
IN-DEPTH ANALYSIS

作者 Adrian Toutoungi

点击此处了解更多

与我会面:

23 七月

16:00 - 17:00

网络研讨会

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

更多